
Fagron NV (FAGR) | Financial Analysis & Statements
Fagron NV | Large-cap | Healthcare
Fagron NV | Large-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2019Income Metrics
EPS (Diluted)
€0.00
Balance Sheet Metrics
Total Assets
1.1B
Total Liabilities
578.2M
Shareholders Equity
505.4M
Debt to Equity
1.14
Cash Flow Metrics
Revenue & Profitability Trend
Fagron NV Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 872.0M | 763.0M | 683.9M | 573.8M | 556.0M |
Cost of Goods Sold | 476.3M | 430.4M | 397.7M | 326.3M | 309.2M |
Gross Profit | 395.7M | 332.6M | 286.2M | 247.5M | 246.7M |
Gross Margin % | 45.4% | 43.6% | 41.8% | 43.1% | 44.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | - |
Other Operating Expenses | 4.2M | 2.3M | 6.1M | 2.3M | 2.8M |
Total Operating Expenses | 4.2M | 2.3M | 6.1M | 2.3M | 2.8M |
Operating Income | 134.4M | 112.7M | 101.2M | 89.9M | 92.4M |
Operating Margin % | 15.4% | 14.8% | 14.8% | 15.7% | 16.6% |
Non-Operating Items | |||||
Interest Income | 4.4M | 5.3M | 4.1M | 1.4M | 753.0K |
Interest Expense | 17.4M | 15.2M | 10.6M | 8.0M | 10.9M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 104.3M | 84.4M | 87.8M | 76.8M | 73.7M |
Income Tax | 23.3M | 13.4M | 17.7M | 15.4M | 13.7M |
Effective Tax Rate % | 22.3% | 15.9% | 20.2% | 20.1% | 18.6% |
Net Income | 81.0M | 71.0M | 70.1M | 61.4M | 60.0M |
Net Margin % | 9.3% | 9.3% | 10.2% | 10.7% | 10.8% |
Key Metrics | |||||
EBITDA | 164.0M | 141.9M | 128.2M | 112.4M | 115.9M |
EPS (Basic) | €1.10 | €0.97 | €0.96 | €0.84 | €0.83 |
EPS (Diluted) | €1.10 | €0.97 | €0.96 | €0.84 | €0.82 |
Basic Shares Outstanding | 72937000 | 73000000 | 72875000 | 72643000 | 72089385 |
Diluted Shares Outstanding | 72937000 | 73000000 | 72875000 | 72643000 | 72089385 |
Income Statement Trend
Fagron NV Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 115.0M | 133.0M | 125.3M | 70.6M | 84.2M |
Short-term Investments | 886.0K | 4.3M | 451.0K | - | - |
Accounts Receivable | 82.0M | 62.1M | 60.7M | 51.9M | 42.1M |
Inventory | 137.0M | 113.9M | 108.3M | 90.8M | 79.8M |
Other Current Assets | 27.7M | 22.6M | 23.2M | -2.0K | -1.0K |
Total Current Assets | 362.6M | 335.9M | 318.0M | 233.7M | 221.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 193.1M | 172.7M | 165.6M | 136.6M | 113.6M |
Goodwill | 955.3M | 917.3M | 893.2M | 791.5M | 753.8M |
Intangible Assets | 61.4M | 48.6M | 33.6M | 30.7M | 24.5M |
Long-term Investments | 553.0K | 2.5M | 13.3M | 1.2M | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 721.0M | 671.1M | 653.0M | 566.7M | 530.9M |
Total Assets | 1.1B | 1.0B | 971.0M | 800.4M | 752.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 114.3M | 104.9M | 97.9M | 83.7M | 72.3M |
Short-term Debt | 9.5M | 9.7M | 19.0M | 14.3M | 71.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | -1.0K | - | 2.0K | 1.0K | 4.2M |
Total Current Liabilities | 194.7M | 175.3M | 171.0M | 145.1M | 200.3M |
Non-Current Liabilities | |||||
Long-term Debt | 376.2M | 357.1M | 380.4M | 321.3M | 284.4M |
Deferred Tax Liabilities | 1.8M | 2.0M | 4.4M | 2.5M | 2.1M |
Other Non-Current Liabilities | - | - | -1.0K | 1.0K | - |
Total Non-Current Liabilities | 383.4M | 364.1M | 389.5M | 329.9M | 294.8M |
Total Liabilities | 578.2M | 539.3M | 560.5M | 475.0M | 495.0M |
Equity | |||||
Common Stock | 524.5M | 524.5M | 521.2M | 520.8M | 514.0M |
Retained Earnings | 264.9M | 206.3M | 150.3M | 95.3M | 47.3M |
Treasury Stock | 23.9M | 21.1M | 18.8M | 18.8M | 18.8M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 505.4M | 467.6M | 410.5M | 325.5M | 257.8M |
Key Metrics | |||||
Total Debt | 385.7M | 366.7M | 399.4M | 335.6M | 355.5M |
Working Capital | 167.9M | 160.6M | 147.0M | 88.6M | 21.6M |
Balance Sheet Composition
Fagron NV Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 104.3M | 84.4M | 87.8M | 76.8M | 73.7M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 1.2M | 2.4M | 1.8M | 3.3M | 1.5M |
Working Capital Changes | -34.8M | -6.3M | -2.1M | -22.7M | -10.2M |
Operating Cash Flow | 97.1M | 104.8M | 92.1M | 68.0M | 80.0M |
Investing Activities | |||||
Capital Expenditures | -26.2M | -20.3M | - | - | - |
Acquisitions | -28.9M | -6.3M | -50.8M | -11.2M | -32.9M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | 0 |
Investing Cash Flow | -55.2M | -26.6M | -50.8M | -11.2M | -32.9M |
Financing Activities | |||||
Share Repurchases | -2.9M | -2.3M | 0 | - | - |
Dividends Paid | -21.0M | -18.3M | -14.6M | -13.0M | -5.8M |
Debt Issuance | 52.5M | 0 | 135.0M | 66.2M | 63.6M |
Debt Repayment | -44.0M | -28.0M | -85.7M | -99.5M | -92.5M |
Financing Cash Flow | -11.1M | -39.9M | 38.7M | -38.0M | -30.0M |
Free Cash Flow | 69.1M | 86.2M | 91.0M | 57.7M | 74.5M |
Net Change in Cash | 30.9M | 38.2M | 80.1M | 18.9M | 17.1M |
Cash Flow Trend
Fagron NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
17.65
Forward P/E
15.64
Price to Book
3.01
Price to Sales
1.67
PEG Ratio
15.64
Profitability Ratios
Profit Margin
9.33%
Operating Margin
15.38%
Return on Equity
17.53%
Return on Assets
8.06%
Financial Health
Current Ratio
1.76
Debt to Equity
80.02
Beta
0.25
Per Share Data
EPS (TTM)
€1.17
Book Value per Share
€6.86
Revenue per Share
€12.60
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fagr | 1.5B | 17.65 | 3.01 | 17.53% | 9.33% | 80.02 |
Argenx SE | 36.2B | 33.97 | 5.78 | 24.72% | 41.03% | 0.71 |
UCB S.A | 35.1B | 26.92 | 3.62 | 14.30% | 19.45% | 29.72 |
Ion Beam | 350.0M | 38.58 | 3.16 | 8.52% | 1.86% | 39.39 |
Nyxoah S.A | 246.8M | -3.59 | 2.62 | -77.44% | 65.67% | 23.79 |
Hyloris | 187.6M | - | 5.84 | -17.81% | -64.98% | 5.65 |
Financial data is updated regularly. All figures are in the company's reporting currency.